Dr. Domankevich is an experienced cancer researcher since 2004. She holds a M.Sc degree from the Tel Aviv University and a Ph.D degree from the University of Haifa, where she studied psycho-neuro-immunology aspects of experimental breast metastases and the mechanisms underlying genomic integrity of cancer resistant mammals. Dr. Domankevich is responsible for the company’s translational research, focusing on combinational treatments with immunotherapy. Dr. Domankevich holds a BSc in Information Systems Engineering from the Technion and had worked in software engineering for eight years.